Tapentadol is partly metabolized with the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicines that enhance or repress the action/expression of one or more of those enzymes, and also with substrates of such enzymes (resulting from Opposition to the enzyme); some enzyme mediators/substrates have to https://malcolmv444xkv9.thenerdsblog.com/profile